<VariationArchive VariationID="90107" VariationName="NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?)" VariationType="Duplication" Accession="VCV000090107" Version="21" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-29" DateCreated="2015-03-24" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="95581" VariationID="90107">
      <GeneList>
        <Gene Symbol="MLH1" FullName="mutL homolog 1" GeneID="4292" HGNC_ID="HGNC:7127" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="36993466" stop="37050846" display_start="36993466" display_stop="37050846" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="37034840" stop="37092336" display_start="37034840" display_stop="37092336" Strand="+" />
          </Location>
          <OMIM>120436</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MLH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MLH1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?)</Name>
      <CanonicalSPDI>NC_000003.12:37050647:TGTT:TGTTTGTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="37050647" stop="37050648" display_start="37050647" display_stop="37050648" variantLength="4" positionVCF="37050647" referenceAlleleVCF="G" alternateAlleleVCF="GTGTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="37092138" stop="37092139" display_start="37092138" display_stop="37092139" variantLength="4" positionVCF="37092138" referenceAlleleVCF="G" alternateAlleleVCF="GTGTT" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.37092139_37092142dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.37092139_37092142dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.37050648_37050651dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.37050648_37050651dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007109.2" sequenceAccession="NG_007109" sequenceVersion="2" change="g.62299_62302dup">
            <Expression>NG_007109.2:g.62299_62302dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053016.1" sequenceAccession="NG_053016" sequenceVersion="1" change="g.131167_131170dup">
            <Expression>NG_053016.1:g.131167_131170dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000249.4" sequenceAccession="NM_000249" sequenceVersion="4" change="c.2266_2269dup" MANESelect="true">
            <Expression>NM_000249.4:c.2266_2269dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000240.1" sequenceAccession="NP_000240" sequenceVersion="1" change="p.Ter757LeuextTer?">
            <Expression>NP_000240.1:p.Ter757LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167617.3" sequenceAccession="NM_001167617" sequenceVersion="3" change="c.1972_1975dup">
            <Expression>NM_001167617.3:c.1972_1975dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161089.1" sequenceAccession="NP_001161089" sequenceVersion="1" change="p.Ter659LeuextTer?">
            <Expression>NP_001161089.1:p.Ter659LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167618.3" sequenceAccession="NM_001167618" sequenceVersion="3" change="c.1543_1546dup">
            <Expression>NM_001167618.3:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161090.1" sequenceAccession="NP_001161090" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001161090.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167619.3" sequenceAccession="NM_001167619" sequenceVersion="3" change="c.1543_1546dup">
            <Expression>NM_001167619.3:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161091.1" sequenceAccession="NP_001161091" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001161091.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258271.2" sequenceAccession="NM_001258271" sequenceVersion="2" change="c.2059_2062dup">
            <Expression>NM_001258271.2:c.2059_2062dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001245200.1" sequenceAccession="NP_001245200" sequenceVersion="1" change="p.Ter688LeuextTer?">
            <Expression>NP_001245200.1:p.Ter688LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258273.2" sequenceAccession="NM_001258273" sequenceVersion="2" change="c.1543_1546dup">
            <Expression>NM_001258273.2:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001245202.1" sequenceAccession="NP_001245202" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001245202.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258274.3" sequenceAccession="NM_001258274" sequenceVersion="3" change="c.1543_1546dup">
            <Expression>NM_001258274.3:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001245203.1" sequenceAccession="NP_001245203" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001245203.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354615.2" sequenceAccession="NM_001354615" sequenceVersion="2" change="c.1543_1546dup">
            <Expression>NM_001354615.2:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341544.1" sequenceAccession="NP_001341544" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001341544.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354616.2" sequenceAccession="NM_001354616" sequenceVersion="2" change="c.1543_1546dup">
            <Expression>NM_001354616.2:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341545.1" sequenceAccession="NP_001341545" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001341545.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354617.2" sequenceAccession="NM_001354617" sequenceVersion="2" change="c.1543_1546dup">
            <Expression>NM_001354617.2:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341546.1" sequenceAccession="NP_001341546" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001341546.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354618.2" sequenceAccession="NM_001354618" sequenceVersion="2" change="c.1543_1546dup">
            <Expression>NM_001354618.2:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341547.1" sequenceAccession="NP_001341547" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001341547.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354619.2" sequenceAccession="NM_001354619" sequenceVersion="2" change="c.1543_1546dup">
            <Expression>NM_001354619.2:c.1543_1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341548.1" sequenceAccession="NP_001341548" sequenceVersion="1" change="p.Ter516LeuextTer?">
            <Expression>NP_001341548.1:p.Ter516LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354620.2" sequenceAccession="NM_001354620" sequenceVersion="2" change="c.1972_1975dup">
            <Expression>NM_001354620.2:c.1972_1975dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341549.1" sequenceAccession="NP_001341549" sequenceVersion="1" change="p.Ter659LeuextTer?">
            <Expression>NP_001341549.1:p.Ter659LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354621.2" sequenceAccession="NM_001354621" sequenceVersion="2" change="c.1243_1246dup">
            <Expression>NM_001354621.2:c.1243_1246dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341550.1" sequenceAccession="NP_001341550" sequenceVersion="1" change="p.Ter416LeuextTer?">
            <Expression>NP_001341550.1:p.Ter416LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354622.2" sequenceAccession="NM_001354622" sequenceVersion="2" change="c.1243_1246dup">
            <Expression>NM_001354622.2:c.1243_1246dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341551.1" sequenceAccession="NP_001341551" sequenceVersion="1" change="p.Ter416LeuextTer?">
            <Expression>NP_001341551.1:p.Ter416LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354623.2" sequenceAccession="NM_001354623" sequenceVersion="2" change="c.1243_1246dup">
            <Expression>NM_001354623.2:c.1243_1246dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341552.1" sequenceAccession="NP_001341552" sequenceVersion="1" change="p.Ter416LeuextTer?">
            <Expression>NP_001341552.1:p.Ter416LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354624.2" sequenceAccession="NM_001354624" sequenceVersion="2" change="c.1192_1195dup">
            <Expression>NM_001354624.2:c.1192_1195dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341553.1" sequenceAccession="NP_001341553" sequenceVersion="1" change="p.Ter399LeuextTer?">
            <Expression>NP_001341553.1:p.Ter399LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354625.2" sequenceAccession="NM_001354625" sequenceVersion="2" change="c.1192_1195dup">
            <Expression>NM_001354625.2:c.1192_1195dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341554.1" sequenceAccession="NP_001341554" sequenceVersion="1" change="p.Ter399LeuextTer?">
            <Expression>NP_001341554.1:p.Ter399LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354626.2" sequenceAccession="NM_001354626" sequenceVersion="2" change="c.1192_1195dup">
            <Expression>NM_001354626.2:c.1192_1195dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341555.1" sequenceAccession="NP_001341555" sequenceVersion="1" change="p.Ter399LeuextTer?">
            <Expression>NP_001341555.1:p.Ter399LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354627.2" sequenceAccession="NM_001354627" sequenceVersion="2" change="c.1192_1195dup">
            <Expression>NM_001354627.2:c.1192_1195dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341556.1" sequenceAccession="NP_001341556" sequenceVersion="1" change="p.Ter399LeuextTer?">
            <Expression>NP_001341556.1:p.Ter399LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354628.2" sequenceAccession="NM_001354628" sequenceVersion="2" change="c.2173_2176dup">
            <Expression>NM_001354628.2:c.2173_2176dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341557.1" sequenceAccession="NP_001341557" sequenceVersion="1" change="p.Ter726LeuextTer?">
            <Expression>NP_001341557.1:p.Ter726LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354629.2" sequenceAccession="NM_001354629" sequenceVersion="2" change="c.2167_2170dup">
            <Expression>NM_001354629.2:c.2167_2170dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341558.1" sequenceAccession="NP_001341558" sequenceVersion="1" change="p.Ter724LeuextTer?">
            <Expression>NP_001341558.1:p.Ter724LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354630.2" sequenceAccession="NM_001354630" sequenceVersion="2" change="c.2101_2104dup">
            <Expression>NM_001354630.2:c.2101_2104dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341559.1" sequenceAccession="NP_001341559" sequenceVersion="1" change="p.Ter702LeuextTer?">
            <Expression>NP_001341559.1:p.Ter702LeuextTer?</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_216" sequenceAccession="LRG_216">
            <Expression>LRG_216:g.62299_62302dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000249.3" sequenceAccession="NM_000249" sequenceVersion="3" change="c.2266_2269dupTGTT">
            <Expression>NM_000249.3:c.2266_2269dupTGTT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA248502" DB="ClinGen" />
        <XRef Type="rs" ID="267607892" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?) AND Lynch syndrome" Accession="RCV000075593" Version="12">
        <ClassifiedConditionList TraitSetID="8777">
          <ClassifiedCondition DB="MedGen" ID="C4552100">Lynch syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2013-09-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?) AND not provided" Accession="RCV000201988" Version="21">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-06-08" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?) AND Hereditary nonpolyposis colorectal neoplasms" Accession="RCV000817018" Version="11">
        <ClassifiedConditionList TraitSetID="37727">
          <ClassifiedCondition DB="MedGen" ID="C0009405">Hereditary nonpolyposis colorectal neoplasms</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?) AND Hereditary nonpolyposis colon cancer" Accession="RCV001269209" Version="9">
        <ClassifiedConditionList TraitSetID="53926">
          <ClassifiedCondition DB="MedGen" ID="C1333990">Hereditary nonpolyposis colon cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-11-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?) AND Hereditary cancer-predisposing syndrome" Accession="RCV002444529" Version="9">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000249.4(MLH1):c.2266_2269dup (p.Ter757LeuextTer?) AND Colorectal cancer, hereditary nonpolyposis, type 2" Accession="RCV003460709" Version="2">
        <ClassifiedConditionList TraitSetID="5637">
          <ClassifiedCondition DB="MedGen" ID="C1333991">Colorectal cancer, hereditary nonpolyposis, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-09-05" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2015-03-24" MostRecentSubmission="2024-06-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10206076</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12810663</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2022152</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2224779</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24362816</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8128251</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8574961</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9697702</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.insight-database.org/classifications/index.html?gene=MLH1&amp;variant=c.2266_2269dup</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="53926" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="53477" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Nonpolyposis Colorectal Cancer Syndrome</ElementValue>
                <XRef ID="C120083" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary nonpolyposis colon cancer</ElementValue>
                <XRef ID="MONDO:0018630" DB="MONDO" />
                <XRef ID="155018" DB="NCBI for submitter" />
                <XRef ID="315058005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary nonpolyposis colorectal cancer</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial nonpolyposis colon cancer</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HNPCC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000568362" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332533" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558908" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568365" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520080" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000325623" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596791" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <XRef ID="443909" DB="Orphanet" />
              <XRef ID="C1333990" DB="MedGen" />
              <XRef ID="MONDO:0018630" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS120435" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8777" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14688" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lynch syndrome</ElementValue>
                <XRef ID="2622" DB="GeneTests" />
                <XRef ID="Hereditary+Non-Polyposis+Colorectal+Cancer+%28HNPCC%29/3371" DB="Genetic Alliance" />
                <XRef ID="MONDO:0005835" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9905" />
                <XRef ID="9905" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000552184" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520080" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558908" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551459" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515774" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520030" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512828" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551463" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000316595" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000322202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522278" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591173" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000321105" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522225" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552440" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561860" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515821" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520867" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551461" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519254" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551464" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527981" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519150" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562151" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522224" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568365" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518997" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518999" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591263" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332519" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552183" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000325623" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520392" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569958" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568362" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520871" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="practice guideline" Abbrev="SGO, 2014">
                <URL>https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer</URL>
                <CitationText>Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="MSTF, 2014">
                <ID Source="PubMed">25070057</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mork et al., 2015">
                <ID Source="PubMed">25711197</ID>
              </Citation>
              <Citation Type="general" Abbrev="Dutch SCG, 2013">
                <ID Source="PubMed">23535968</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mallorca group, 2013">
                <ID Source="PubMed">23408351</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Goldberg et al, 2019">
                <ID Source="PubMed">31302137</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C4552100" DB="MedGen" />
              <XRef ID="MONDO:0005835" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5637" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4825" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lynch syndrome II</ElementValue>
                <Citation Type="general" Abbrev="Vasen et al., 2007">
                  <ID Source="pmc">2740877</ID>
                </Citation>
                <XRef ID="Colorectal+Cancer%2C+Hereditary+Nonpolyposis%2C+Type+2/1749" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary non-polyposis colorectal cancer, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Colorectal cancer, hereditary nonpolyposis, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MLH1-Related Lynch Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HNPCC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COCA2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FCC2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LYNCH2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15457" />
                <XRef ID="15457" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MLH1-Related Hereditary Non-Polyposis Colon Cancer</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000595970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501796" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508803" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332358" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000317453" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520048" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508796" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000326160" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508789" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501396" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260599" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501398" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508795" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505560" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="practice guideline" Abbrev="SGO, 2014">
                <URL>https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer</URL>
                <CitationText>Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="MSTF, 2014">
                <ID Source="PubMed">25070057</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mork et al., 2015">
                <ID Source="PubMed">25711197</ID>
              </Citation>
              <Citation Type="general" Abbrev="Dutch SCG, 2013">
                <ID Source="PubMed">23535968</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mallorca group, 2013">
                <ID Source="PubMed">23408351</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC/CCA-ICC, 2012">
                <ID Source="PubMed">22167527</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C1333991" DB="MedGen" />
              <XRef ID="MONDO:0012249" DB="MONDO" />
              <XRef Type="MIM" ID="609310" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="37727" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="38245" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary nonpolyposis colorectal neoplasms</ElementValue>
                <XRef ID="D003123" DB="MeSH" />
              </Name>
              <XRef ID="C0009405" DB="MedGen" />
              <XRef ID="D003123" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="479561" SubmissionDate="2015-11-19" DateLastUpdated="2015-11-20" DateCreated="2015-11-20">
        <ClinVarSubmissionID localKey="195" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000257092" DateUpdated="2015-11-20" DateCreated="2015-11-20" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="0" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000249.3:c.2266_2269dupTGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MC_20151112</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2860259" SubmissionDate="2020-12-02" DateLastUpdated="2020-12-07" DateCreated="2020-12-07">
        <ClinVarSubmissionID localKey="NM_000249.3:c.2266_2269dupTGTT|MedGen:C1333990" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001448515" DateUpdated="2020-12-07" DateCreated="2020-12-07" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12810663</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8574961</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8128251</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9697702</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24362816</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10206076</ID>
          </Citation>
          <Comment>Variant summary: MLH1 c.2266_2269dupTGTT (p.X757LeufsX35) causes a frameshift which results in an extension of the protein with additional 34 amino acids. The variant was absent in 251260 control chromosomes (gnomAD). c.2266_2269dupTGTT has been reported in the literature in individuals affected with colorectal cancer and Lynch syndrome and this variant was shown to segregate with disease in a family (Papadopoulos_1994, Liu_1996, Boyd_1999, ClinVar labs). These data indicate that the variant may be associated with disease. In vitro studies report this variant reduced mutation rate, beta-gal activity and results in decreasing the interaction with associated proteins. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. In addition, one expert panel, International Society for Gastrointestinal Hereditary Tumours (InSiGHT), classified this variant as pathogenic in ClinVar in 2013 (Thompson_2014). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000249.3:c.2266_2269dupTGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hereditary nonpolyposis colon cancer</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1333990" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8677443</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1203961" SubmissionDate="2021-06-06" DateLastUpdated="2019-08-14" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDXSV:3007" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000617553" DateUpdated="2019-08-14" DateCreated="2017-12-19" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This duplication of 4 nucleotides in MLH1 is denoted c.2266_2269dupTGTT at the cDNA level andp.X757LextX35 at the protein level. The normal sequence, with the bases that are duplicated in brackets, isGAGG[dupTGTT]AAat where the capital letters are exonic and lowercase are intronic. The duplication causes aframeshift, which changes a stop codon to a Leucine at codon 2266 in the last exon of the gene, and results in anextension of the protein. The native termination codon is replaced by 34 incorrect amino acids. This variant, alsopublished as 2266ins4 or 756ins4bp, was found to segregate with disease in a large family that met Amsterdam IIcriteria (Lynch 1990, Papadopoulos 1994, Boyd 1999). Internal observations also show this variant segregating inindividuals with personal histories consistent with Lynch syndrome. This variant was shown to lead to a reduction in thedominant mutator effect, near absent beta-gal activity, and decreased interaction with PMS2 (Shimodaira 1998, Kondo2003). In addition, The International Society for Gastrointestinal Hereditary Tumours Incorporated (InSiGHT) classifiesthis variant as pathogenic (Thompson 2014). Based on currently available information, we consider this to be a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:702530</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000249.3:c.2266_2269dupTGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_3_20210603085438</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="185439" SubmissionDate="2013-12-18" DateLastUpdated="2022-12-24" DateCreated="2013-12-19">
        <ClinVarSubmissionID localKey="c.2266_2269dup" />
        <ClinVarAccession Accession="SCV000106590" DateUpdated="2022-12-24" DateCreated="2013-12-19" Type="SCV" Version="3" SubmitterName="International Society for Gastrointestinal Hereditary Tumours (InSiGHT)" OrgID="500189" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-09-05">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Multifactorial likelihood analysis posterior probability &gt;0.99</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Guidelines v1.9</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/jgfvdvht/2013-08_insight_vic_v1.9.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000249.3:c.2266_2269dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Lynch Syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>Classified with v1.9 guidelines: https://docs.google.com/file/d/0B3JL6rP6JzhoN2EydHRVMEI1UGs</Comment>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1851800" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4842412|MedGen:C0009405" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000957554" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2224779</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8128251</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10206076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9697702</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12810663</ID>
          </Citation>
          <Comment>This sequence change results in a frameshift in the MLH1 gene (p.*757Leuext*34). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the stop codon of the MLH1 protein and extend the protein by 34 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This frameshift has been observed in individual(s) with clinical features of Lynch syndrome (PMID: 2224779, 8128251, 10206076; Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as 755_756ins4 and 756ins4. ClinVar contains an entry for this variant (Variation ID: 90107). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this frameshift affects MLH1 function (PMID: 9697702, 12810663). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.37092138_37092139insTGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0009405" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5217387" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a691992|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002736591" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10206076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12810663</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2022152</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2224779</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24362816</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8128251</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8574961</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9697702</ID>
          </Citation>
          <Comment>The c.2266_2269dupTGTT pathogenic mutation (also known as p.*757Lext*34), located in coding exon 19 of the MLH1 gene, results from a duplication of TGTT at nucleotide position 2266. This alteration disrupts the stop codon of the MLH1 gene and is predicted to preserve the native sequence while resulting in the elongation of the protein by 34 amino acids. However, this alteration has been reported in Lynch syndrome families and showed moderate segregation with disease in these families (Ambry internal data; Lynch HT et al. Cancer, 1990 Nov;66:2233-8; Papadopoulos N et al. Science, 1994 Mar;263:1625-9; Liu B et al. Nat. Med., 1996 Feb;2:169-74 Boyd J et al. Breast Cancer Res. Treat., 1999 Jan;53:87-91; ). Functional studies performed in yeast demonstrated defective PMS2 interaction and a reduced dominant mutator effect for this alteration (Kondo E et al. Cancer Res., 2003 Jun;63:3302-8; Shimodaira H et al. Nat. Genet., 1998 Aug;19:384-9). Based on an internal structural assessment, this alteration is expected to detrimentally impact MLH1/PMS2 dimerization by binding to the dimerization interface (Ambry internal data). Of note, this alteration is often described as a 4-bp insertion in codons 755-756 in published literature. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000249.3:c.2266_2269dupTGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7844218" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000249.4:c.2266_2269dup|OMIM:609310" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004195051" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000249.4:c.2266_2269dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609310" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4016049" SubmissionDate="2022-01-04" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="3087033|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002047711" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MLH1 c.2266_2269dupTGTT; p.Ter757LeuextTer34 variant, is reported in the literature in multiple individuals affected with Lynch syndrome and segregates with disease in a large kindred (Boyd 1999, Lynch 1990, Papadopoulos 1994). In vitro/In vivo functional analyses demonstrate a reduction in the dominant mutator effect and a decreased interaction with PMS2 (Kondo 2003, Shimodaira 1998). This variant is reported in ClinVar (Variation ID: 90107). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by inserting four nucleotides resulting in the disruption of the stop codon and the extension of the protein with an additional 34 amino acids. Based on available information, this variant is considered to be pathogenic. References: Boyd J et al. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat. 1999 Jan;53(1):87-91. PMID: 10206076. Kondo E et al. A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. Cancer Res. 2003 Jun 15;63(12):3302-8. PMID: 12810663. Lynch HT et al. Genetic diagnosis of Lynch syndrome II in an extended colorectal cancer-prone family. Cancer. 1990 Nov 15;66(10):2233-8. PMID: 2224779. Papadopoulos N et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994 Mar 18;263(5153):1625-9. PMID: 8128251. Shimodaira H et al. Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet. 1998 Aug;19(4):384-9. PMID: 9697702.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ythvkvge/arup_molecular_germline_variant_investigation_process_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.37092139_37092142dupTGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ARUP Molecular 2021</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2860259" TraitType="Disease" MappingType="Name" MappingValue="Hereditary nonpolyposis colon cancer" MappingRef="Preferred">
        <MedGen CUI="C1333990" Name="Hereditary nonpolyposis colon cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="185439" TraitType="Disease" MappingType="Name" MappingValue="Lynch Syndrome" MappingRef="Preferred">
        <MedGen CUI="C4552100" Name="Lynch syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7844218" TraitType="Disease" MappingType="XRef" MappingValue="609310" MappingRef="OMIM">
        <MedGen CUI="C1333991" Name="Colorectal cancer, hereditary nonpolyposis, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1203961" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5217387" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="479561" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4016049" TraitType="Finding" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1851800" TraitType="Disease" MappingType="XRef" MappingValue="C0009405" MappingRef="MedGen">
        <MedGen CUI="C0009405" Name="Hereditary nonpolyposis colorectal neoplasms" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

